Annovis Bio Inc. (ANVS): Price and Financial Metrics
ANVS Price/Volume Stats
| Current price | $4.37 | 52-week high | $22.49 |
| Prev. close | $4.40 | 52-week low | $4.30 |
| Day low | $4.30 | Volume | 330,100 |
| Day high | $4.53 | Avg. volume | 718,486 |
| 50-day MA | $7.36 | Dividend yield | N/A |
| 200-day MA | $8.49 | Market Cap | 60.29M |
ANVS Stock Price Chart Interactive Chart >
Annovis Bio Inc. (ANVS) Company Bio
Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.
ANVS Price Returns
| 1-mo | -35.64% |
| 3-mo | -48.41% |
| 6-mo | -28.24% |
| 1-year | -69.80% |
| 3-year | -78.36% |
| 5-year | N/A |
| YTD | -76.63% |
| 2023 | 39.24% |
| 2022 | -23.61% |
| 2021 | 133.16% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...